Table.
Paradigm | Consensus | Knowledge gap and needed work |
---|---|---|
Epidemiology | • Stratified understanding of high risk: Neonates, heart disease, chronic kidney disease, sepsis, cystic fibrosis, transplant history, oncologic history, chronic liver disease |
• Middle- and low-income populations • Expanded AKI phenotypes |
Diagnostics | • Biomarker-based delineation of standard vs high risk | • Integration of concurrent diagnostics • Differentiation of diagnostics over time |
Fluid balance | • Use of percent fluid balance and anchor weight (ICU admission weight) | • Adjudicate “fluid overload” by illness state |
KST | • Institute benchmarks and components of KST team • Need for pediatric specific extracorporeal therapies |
• KST team, quality, and cost optimization • KST integration of tandem therapies |
Biopathology | • Pediatrics incorporated into research efforts • Importance of nephrotoxin stewardship programs • Promoting bench-bedside collaboration between preclinical, epidemiological and clinical trial researchers |
• Determination of sex as a biological variable related to AKI • Characterize medications affected by AKI across developmental spectrum • Identify the optimal nutritional interventions by age for AKI |
Education and advocacy | • Differential approach based on national resources • Integration of electronic medical record/checklists |
• Governmentaland community partnerships • Cross-discipline health care training |
Abbreviations: AKI, acute kidney injury; ICU, intensive care unit; KST, kidney support therapy.